About: Inhalable insulin

Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inhalable insulin Sponge Permalink

An Entity of Type : owl:Thing, within Data Space : 134.155.108.49:8890 associated with source dataset(s)

Inhalable insulin is a new (as of mid-2006) method of delivering insulin, a drug used in the treatment of diabetes, to the body. It is the first new treatment option of insulin since the discovery of insulin in 1921[1], traditionally administered by subcutaneous injection.

Attributes	Values
rdfs:label	Inhalable insulin
rdfs:comment	Inhalable insulin is a new (as of mid-2006) method of delivering insulin, a drug used in the treatment of diabetes, to the body. It is the first new treatment option of insulin since the discovery of insulin in 1921[1], traditionally administered by subcutaneous injection.
sameAs	dbr:Inhalable_insulin
dcterms:subject	Treatments
dbkwik:diabetes/pr...iPageUsesTemplate	dbkwik:resource/vn3G7JHswRER3tbHDNK8Yw==
abstract	Inhalable insulin is a new (as of mid-2006) method of delivering insulin, a drug used in the treatment of diabetes, to the body. It is the first new treatment option of insulin since the discovery of insulin in 1921[1], traditionally administered by subcutaneous injection. It is a powdered form of recombinant human insulin, which is delivered through an inhaler into the lungs where it is absorbed[2]. As of March 2007, the currently available type (Exubera) is a fast or rapid acting form of insulin [3], meaning that once it has been absorbed, it begins working within the body over the next few hours. Diabetics still need to take a longer acting basal insulin by injection[4]. Several companies are developing inhaled forms of the drug to reduce the need for daily injections among diabetics.

OpenLink Virtuoso version 07.20.3217, on Linux (x86_64-pc-linux-gnu), Standard Edition
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2012 OpenLink Software